Nanotechnology Advances for Breast Cancer Treatment
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 66
Special Issue Editors
Interests: lipid-based carriers; drug delivery systems; in vivo assays; clinical assays
Special Issues, Collections and Topics in MDPI journals
Interests: nanostructured lipid carrier; drug delivery systems
Special Issue Information
Dear Colleagues,
Nanotechnology is a promising technology that has an important impact on the therapeutic field. These nanosystems can deliver several drugs specifically to cancer cells by passive and active mechanisms. For these purposes, different nano delivery systems have been studied and demonstrated great results, such as lipid-based (e.g., liposomes, nanostructured lipid carriers, and nanoemulsion), polymer-based (e.g., polymeric nanoparticles, micelles, and dendrimers), and inorganic nanoparticles (e.g., gold, silver and silica nanoparticles).
In this context, we invite you to contribute to the Special Issue entitled “Nanotechnology Advances for Breast Cancer Treatment” with an original research article, or review. The main goal of this Special Issue is to present the recent advances in the development and characterization of nanoparticles for the treatment of breast cancer.
Dr. Marlus Chorilli
Dr. Marcela Tavares Luiz
Dr. Pietro Rosemeire Cristina Linhari Rodrigues
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- active targeting
- breast cancer
- cancer therapy
- drug delivery systems
- nanoparticles
- nanosystems
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
